The Efficacy and Safety of REX-001 to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DM

Clinical trial NCT03174522 · TERMINATED

Trial details

NCT number: NCT03174522
Sponsor: Ixaka Ltd
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Peripheral Arterial Disease (PAD)Diabetes Mellitus (DM)Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2 Cardiovascular Disease Critical Limb Ischemia (CLI)

Start date: 2017-04-25
Primary completion: 2023-02-13
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.